{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:32:23Z","timestamp":1778711543331,"version":"3.51.4"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.berh.2022.101764","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T21:47:20Z","timestamp":1655934440000},"page":"101764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Is it really myositis? Mimics and pitfalls"],"prefix":"10.1016","volume":"36","author":[{"given":"Salman F.","family":"Bhai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen M.","family":"Dimachkie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"de Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.berh.2022.101764_bib1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","article-title":"Autoantibodies in myositis","volume":"14","author":"McHugh","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2022.101764_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis","volume":"280","author":"Betteridge","year":"2016","journal-title":"J Intern Med"},{"key":"10.1016\/j.berh.2022.101764_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2017.06.007","article-title":"Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort","volume":"84","author":"Tansley","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.berh.2022.101764_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","article-title":"Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients","volume":"101","author":"Betteridge","year":"2019","journal-title":"J Autoimmun"},{"issue":"11","key":"10.1016\/j.berh.2022.101764_bib5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/ard.2005.045690","article-title":"Long-term outcome in polymyositis and dermatomyositis","volume":"65","author":"Bronner","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2022.101764_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Prim"},{"issue":"7","key":"10.1016\/j.berh.2022.101764_bib7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis: (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.berh.2022.101764_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis: (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.berh.2022.101764_bib9","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2022.101764_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2019.101484","article-title":"Inflammatory muscle disease \u2013 an update","volume":"34","author":"Baig","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2022.101764_bib11","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/BOR.0000000000000549","article-title":"Recent developments in classification criteria and diagnosis guidelines for idiopathic inflammatory myopathies","volume":"30","author":"Oldroyd","year":"2018","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2022.101764_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JND-180308","article-title":"Current classification and management of inflammatory myopathies","volume":"5","author":"Schmidt","year":"2018","journal-title":"J Neuromuscul Dis"},{"issue":"9","key":"10.1016\/j.berh.2022.101764_bib13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O\u2019Callaghan","year":"2018","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.berh.2022.101764_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","article-title":"Classification of myositis","volume":"14","author":"Lundberg","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2022.101764_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nan.12380","article-title":"Integrated classification of inflammatory myopathies","volume":"43","author":"Allenbach","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"10.1016\/j.berh.2022.101764_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","article-title":"239th ENMC international workshop: classification of dermatomyositis, amsterdam, The Netherlands, 14\u201316 december 2018","volume":"30","author":"Mammen","year":"2020","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.berh.2022.101764_bib17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13075-017-1383-0","article-title":"RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis","volume":"19","author":"Su\u00e1rez-Calvet","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.berh.2022.101764_bib18","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3899\/jrheum.141443","article-title":"The prevalence of individual histopathologic features varies according to autoantibody status in muscle biopsies from patients with dermatomyositis","volume":"42","author":"Pinal-Fernandez","year":"2015","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2022.101764_bib19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/nan.12519","article-title":"Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis","volume":"45","author":"Uruha","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"8","key":"10.1016\/j.berh.2022.101764_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11926-013-0349-8","article-title":"Clinical heterogeneity and outcomes of antisynthetase syndrome","volume":"15","author":"Hervier","year":"2013","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.berh.2022.101764_bib21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.semarthrit.2020.09.020","article-title":"Antisynthetase syndrome \u2013 much more than just a myopathy","volume":"51","author":"Opinc","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.berh.2022.101764_bib22","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.3390\/jcm8112013","article-title":"Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course","volume":"8","author":"Trallero-Aragu\u00e1s","year":"2019","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.berh.2022.101764_bib23","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamaneurol.2017.0934","article-title":"Skeletal muscle involvement in antisynthetase syndrome","volume":"74","author":"Noguchi","year":"2017","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.berh.2022.101764_bib24","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/brain\/awv192","article-title":"Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis","volume":"138","author":"Mescam-Mancini","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.berh.2022.101764_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/acr.21671","article-title":"Increased frequency of DRB1\u221711:01 in anti-HMG-CoA reductase-associated autoimmune myopathy","author":"Mammen","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"9","key":"10.1016\/j.berh.2022.101764_bib26","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2022.101764_bib27","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1212\/NXI.0000000000000513","article-title":"Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy","volume":"6","author":"Lim","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"8","key":"10.1016\/j.berh.2022.101764_bib28","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/aww054","article-title":"High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody","volume":"139","author":"Allenbach","year":"2016","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.berh.2022.101764_bib29","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s13311-018-0658-8","article-title":"Inclusion body myositis: update on pathogenesis and treatment","volume":"15","author":"Naddaf","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.berh.2022.101764_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41584-019-0186-x","article-title":"Inclusion body myositis: clinical features and pathogenesis","volume":"15","author":"Greenberg","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2022.101764_bib31","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00415-009-5229-9","article-title":"Detecting dysphagia in inclusion body myositis","volume":"256","author":"Cox","year":"2009","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.berh.2022.101764_bib32","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/BOR.0000000000000327","article-title":"Epidemiology of sporadic inclusion body myositis","volume":"28","author":"\u00d8","year":"2016","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2022.101764_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/acr.22600","article-title":"Cytosolic 5\u2032-nucleotidase 1A as a target of circulating autoantibodies in autoimmune diseases: circulating autoantibodies against cytosolic 5\u2032-nt1a","volume":"68","author":"Lloyd","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.berh.2022.101764_bib34","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/annrheumdis-2014-206691","article-title":"Disease specificity of autoantibodies to cytosolic 5\u2032-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases","volume":"75","author":"Herbert","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"15","key":"10.1016\/j.berh.2022.101764_bib35","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1212\/WNL.0000000000003821","article-title":"Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients","volume":"88","author":"Lloyd","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.berh.2022.101764_bib36","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/119.6.1887","article-title":"Inclusion body myositis in HIV-1 and HTLV-1 infected patients","volume":"119","author":"Cupler","year":"1996","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.berh.2022.101764_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.nmd.2014.12.005","article-title":"Inclusion body myositis and sarcoid myopathy: coincidental occurrence or associated diseases","volume":"25","author":"Sanmaneechai","year":"2015","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.berh.2022.101764_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1212\/WNL.0000000000002291","article-title":"Hepatitis C virus infection in inclusion body myositis: a case-control study","volume":"86","author":"Uruha","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.berh.2022.101764_bib39","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1212\/WNL.0000000000004333","article-title":"Clinicopathologic features of myositis patients with CD8-MHC-1 complex pathology","volume":"89","author":"Ikenaga","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.berh.2022.101764_bib40","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0889-857X(02)00030-3","article-title":"Muscle biopsy findings in inflammatory myopathies","volume":"28","author":"Dalakas","year":"2002","journal-title":"Rheum Dis Clin N Am"},{"issue":"2","key":"10.1016\/j.berh.2022.101764_bib41","first-page":"103","article-title":"Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis","volume":"30","author":"Dubourg","year":"2011","journal-title":"Acta Myol Myopathies Cardiomyopathies Off J Mediterr Soc Myol"},{"key":"10.1016\/j.berh.2022.101764_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2017.07.002","article-title":"Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts","volume":"472","author":"Muro","year":"2017","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.berh.2022.101764_bib43","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","article-title":"Polymyositis: an overdiagnosed entity","volume":"61","author":"van der Meulen","year":"2003","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.berh.2022.101764_bib44","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00296-014-3198-5","article-title":"Polymyositis, a very uncommon isolated disease: clinical and histological re-evaluation after long-term follow-up","volume":"35","author":"Vilela","year":"2015","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.berh.2022.101764_bib45","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1093\/rheumatology\/keab166","article-title":"A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies","volume":"60","author":"Oldroyd","year":"2021","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2022.101764_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13075-017-1469-8","article-title":"Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study","volume":"19","author":"Yang","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.berh.2022.101764_bib47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MNM.0000000000000981","article-title":"18F-FDG PET\/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications","volume":"40","author":"Maliha","year":"2019","journal-title":"Nucl Med Commun"},{"issue":"6","key":"10.1016\/j.berh.2022.101764_bib48","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","article-title":"Conventional cancer screening versus PET\/CT in dermatomyositis\/polymyositis","volume":"123","author":"Selva-O\u2019Callaghan","year":"2010","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.berh.2022.101764_bib49","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s10072-003-0158-3","article-title":"Creatine kinase activity in amyotrophic lateral sclerosis patients","volume":"24","author":"Ilzecka","year":"2003","journal-title":"Neurol Sci"},{"issue":"3","key":"10.1016\/j.berh.2022.101764_bib50","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00131402-200103000-00008","article-title":"Creatine kinase revisited","volume":"2","author":"Katiriji","year":"2001","journal-title":"J Clin Neuromuscul Dis"},{"issue":"7","key":"10.1016\/j.berh.2022.101764_bib51","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/rheumatology\/ket162","article-title":"Pulmonary impairment, not muscle injury, is associated with elevated ESR in the idiopathic inflammatory myopathies","volume":"52","author":"Park","year":"2013","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2022.101764_bib52","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ncl.2021.06.007","article-title":"Electrodiagnostic assessment of myopathy","volume":"39","author":"Martinez-Thompson","year":"2021","journal-title":"Neurol Clin"},{"issue":"3","key":"10.1016\/j.berh.2022.101764_bib53","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mus.26381","article-title":"Needle electromyography and histopathologic correlation in myopathies","volume":"59","author":"Sener","year":"2019","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.berh.2022.101764_bib54","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ncl.2004.03.008","article-title":"MRI in myopathy","volume":"22","author":"Lovitt","year":"2004","journal-title":"Neurol Clin"},{"issue":"2","key":"10.1016\/j.berh.2022.101764_bib55","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jmri.20804","article-title":"Muscle MRI in inherited neuromuscular disorders: past, present, and future","volume":"25","author":"Mercuri","year":"2007","journal-title":"J Magn Reson Imag"},{"issue":"7","key":"10.1016\/j.berh.2022.101764_bib56","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jnen\/nlaa046","article-title":"What every neuropathologist needs to know: the muscle biopsy","volume":"79","author":"Nix","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"issue":"7","key":"10.1016\/j.berh.2022.101764_bib57","first-page":"1591","article-title":"Percutaneous conchotome muscle biopsy. A useful diagnostic and assessment tool","volume":"28","author":"Dorph","year":"2001","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2022.101764_bib58","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/CON.0000000000000399","article-title":"Facioscapulohumeral muscular dystrophy","volume":"22","author":"Statland","year":"2016","journal-title":"Contin Lifelong Learn Neurol"},{"issue":"1","key":"10.1016\/j.berh.2022.101764_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-5728(95)00122-0","article-title":"Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls","volume":"63","author":"Lundberg","year":"1995","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1016\/j.berh.2022.101764_bib60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1365-2990.2002.00417.x","article-title":"Muscle pathology in dysferlin deficiency","volume":"28","author":"Fanin","year":"2002","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"7","key":"10.1016\/j.berh.2022.101764_bib61","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.5858\/2007-131-1070-MHCCIA","article-title":"Major histocompatibility complex class I and II detection as a diagnostic tool in idiopathic inflammatory myopathies","volume":"131","author":"Jain","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.berh.2022.101764_bib62","first-page":"136","article-title":"Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies","volume":"75","author":"van der Pas","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.berh.2022.101764_bib63","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.nmd.2014.06.436","article-title":"An analysis of the sensitivity and specificity of MHC-I and MHC-II immunohistochemical staining in muscle biopsies for the diagnosis of inflammatory myopathies","volume":"24","author":"Rodr\u00edguez Cruz","year":"2014","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"10.1016\/j.berh.2022.101764_bib64","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/acr.22088","article-title":"Clinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophy: features distinguishing juvenile polymyositis and dystrophies","volume":"65","author":"Mamyrova","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.berh.2022.101764_bib65","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1055\/s-0035-1558982","volume":"35","author":"Brandsema","year":"2015","journal-title":"Dystrophinopathies. Semin Neurol."},{"issue":"10","key":"10.1016\/j.berh.2022.101764_bib66","doi-asserted-by":"crossref","first-page":"18168","DOI":"10.3390\/molecules201018168","article-title":"Duchenne muscular dystrophy: from diagnosis to therapy","volume":"20","author":"Falzarano","year":"2015","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.berh.2022.101764_bib67","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1007\/s10072-020-04453-y","article-title":"Anoctamin 5 (ANO5) muscular dystrophy\u2014three different phenotypes and a new histological pattern","volume":"41","author":"Segu\u00ed","year":"2020","journal-title":"Neurol Sci"},{"issue":"S13","key":"10.1016\/j.berh.2022.101764_bib68","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1002\/mus.880181312","article-title":"Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses","volume":"18","author":"Arahata","year":"1995","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.berh.2022.101764_bib69","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jnnp.68.6.750","article-title":"Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study","volume":"68","author":"Duyff","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.berh.2022.101764_bib70","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.rdc.2010.09.001","article-title":"Musculoskeletal manifestations of thyroid disease","volume":"36","author":"Anwar","year":"2010","journal-title":"Rheum Dis Clin N Am"},{"issue":"1","key":"10.1016\/j.berh.2022.101764_bib71","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/mus.24637","article-title":"Necrotizing myopathy caused by central hypothyroidism","volume":"52","author":"Tiniakou","year":"2015","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.berh.2022.101764_bib72","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0022-510X(79)90072-8","article-title":"Neuromuscular transmission in thyrotoxicosis","volume":"43","author":"Puvanendran","year":"1979","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.berh.2022.101764_bib73","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0022-510X(69)90010-0","article-title":"Muscular weakness in osteomalacia and hyperparathyroidism","volume":"8","author":"Smith","year":"1969","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.berh.2022.101764_bib74","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-80-2-182","article-title":"Neuromuscular disease in primary hyperparathyroidism","volume":"80","author":"Patten","year":"1974","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.berh.2022.101764_bib75","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/WCO.0000000000000606","article-title":"Toxic myopathies","volume":"31","author":"Pasnoor","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.berh.2022.101764_bib76","first-page":"1634","article-title":"Toxic Myopathies: Contin Lifelong Learn Neurol","volume":"19","author":"Mammen","year":"2013"},{"issue":"6","key":"10.1016\/j.berh.2022.101764_bib77","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.bor.0000434673.85515.89","article-title":"The spectrum of statin myopathy","volume":"25","author":"Mohassel","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2022.101764_bib78","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0002-9343(89)90352-5","article-title":"Nicotinic acid-associated myopathy: a report of three cases","volume":"86","author":"Litin","year":"1989","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.berh.2022.101764_bib79","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-140-8-200404200-00034","article-title":"Ezetimibe and statin-associated myopathy","volume":"140","author":"Fux","year":"2004","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.berh.2022.101764_bib80","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.amjmed.2005.06.051","article-title":"Monotherapy with ezetimibe causing myopathy","volume":"119","author":"Havranek","year":"2006","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.berh.2022.101764_bib81","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.41.7.1159","article-title":"Cholesterol-lowering agent myopathy (CLAM)","volume":"41","author":"London","year":"1991","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.berh.2022.101764_bib82","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4103\/2230-8210.117215","article-title":"Glucocorticoid-induced myopathy: pathophysiology, diagnosis, and treatment","volume":"17","author":"Gupta","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.berh.2022.101764_bib83","series-title":"Disorders of voluntary muscle [internet]","article-title":"Drug-induced neuromuscular disorders","author":"Argov","year":"1988"},{"key":"10.1016\/j.berh.2022.101764_bib84","series-title":"Neuromuscular disorders","first-page":"737","article-title":"Toxic myopathies","author":"Amato","year":"2016"},{"issue":"Supplement_7","key":"10.1016\/j.berh.2022.101764_bib85","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kez295","article-title":"Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy","volume":"58","author":"Kostine","year":"2019","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.berh.2022.101764_bib86","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1212\/WNL.0000000000004359","article-title":"Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan","volume":"89","author":"Suzuki","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.berh.2022.101764_bib87","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1212\/CON.0000000000000403","article-title":"Metabolic myopathies","volume":"22","author":"Tarnopolsky","year":"2016","journal-title":"Contin Lifelong Learn Neurol"},{"key":"10.1016\/j.berh.2022.101764_bib88","series-title":"Neuromuscular notes: diagnosing metabolic myopathies","author":"Bhai","year":"2021"},{"issue":"9","key":"10.1016\/j.berh.2022.101764_bib89","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneur.59.9.1395","article-title":"Spontaneous \u201csecond wind\u201d and glucose-induced second \u201csecond wind\u201d in McArdle disease: oxidative mechanisms","volume":"59","author":"Haller","year":"2002","journal-title":"Arch Neurol"},{"issue":"12","key":"10.1016\/j.berh.2022.101764_bib90","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1212\/WNL.56.12.1733","article-title":"A non-ischemic forearm exercise test for the screening of patients with exercise intolerance","volume":"56","author":"Hogrel","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.berh.2022.101764_bib91","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/brain\/awg028","article-title":"The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients","volume":"126","author":"Taivassalo","year":"2003","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.berh.2022.101764_bib92","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/WCO.0000000000000129","article-title":"Sporadic inclusion body myositis: new insights and potential therapy","volume":"27","author":"Machado","year":"2014","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"10.1016\/j.berh.2022.101764_bib93","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/mus.26914","article-title":"Myopathies with finger flexor weakness: not only inclusion-body myositis","volume":"62","author":"Nicolau","year":"2020","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.berh.2022.101764_bib94","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00415-014-7570-x","article-title":"Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases","volume":"262","author":"Bouchard","year":"2015","journal-title":"J Neurol"},{"issue":"9","key":"10.1016\/j.berh.2022.101764_bib95","doi-asserted-by":"crossref","first-page":"e910","DOI":"10.1212\/WNL.0000000000008863","article-title":"Granulomatosis-associated myositis: high prevalence of sporadic inclusion body myositis","volume":"94","author":"Dieudonn\u00e9","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.berh.2022.101764_bib96","doi-asserted-by":"crossref","first-page":"28","DOI":"10.17161\/rrnmf.v1i4.13699","article-title":"Amyloid myopathy as an inclusion body myositis mimic","volume":"1","author":"Heim","year":"2020","journal-title":"RRNMF Neuromuscul J"},{"issue":"4","key":"10.1016\/j.berh.2022.101764_bib97","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/mus.10528","article-title":"Amyloid myopathy presenting with distal atrophic weakness","volume":"29","author":"Smestad","year":"2004","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.berh.2022.101764_bib98","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.nmd.2014.12.001","article-title":"205th ENMC international workshop: pathology diagnosis of idiopathic inflammatory myopathies Part II 28\u201330 march 2014, naarden, The Netherlands","volume":"25","author":"De Bleecker","year":"2015","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"10.1016\/j.berh.2022.101764_bib99","doi-asserted-by":"crossref","first-page":"e889","DOI":"10.1212\/WNL.0000000000008005","article-title":"Idiopathic inflammatory myopathy: interrater variability in muscle biopsy reading","volume":"93","author":"Olivier","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.berh.2022.101764_bib100","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00415-014-7313-z","article-title":"Long-term follow-up of 62 patients with myositis","volume":"261","author":"van de Vlekkert","year":"2014","journal-title":"J Neurol"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694222000237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694222000237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:22:18Z","timestamp":1761499338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694222000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1521694222000237"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2022.101764","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is it really myositis? Mimics and pitfalls","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2022.101764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101764"}}